JLABS @ San Diego

The lack of early-stage capital and de-risking support is a major challenge in advancing promising biomedical technologies from research labs to commercial partners. Federal agencies are stepping up to support innovators who take on the hardest challenges in emerging, transformative biomedical and health technologies. In this funding environment, start-up companies are increasingly looking to bridge..

Perfecting Your Pitch The things most people don't know that will help you stand out, win millions, close the deal and succeed. Have you ever wondered why you didn't get the deal, project, promotion, etc.? The decision-makers loved the idea. They loved the team. They loved everything you presented, but they wanted to think about..

What if you could improve tissue strength and restore the function of vascular tissue like those undergoing abdominal laparotomy for surgical oncology or in patients with complex surgical sites from diabetic limb salvage and trauma? Meet Westbrook Weaver, Founder, and CEO of Tempo Therapeutics, working hard on the goal of using tissue engineering to build..

Fireside Chat With Isaac Veinbergs From Libra Therapeutics   What if there was a way to restore the cellular balance disrupted in neurodegenerative diseases like Alzheimer's, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Parkinson's, and Huntington's Disease, which are all characterized by cellular disequilibrium caused by the production and decreased clearance of neurotoxic proteins? Meet Isaac Veinbergs, President..